Clinical Trial Update: Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for accelerator-based boron neutron capture therapy (BNCT) in head and neck cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• BNCT (boron neutron capture therapy) (boron neutron capture therapy)

Snippet

Sponsor: Neutron Therapeutics, LLC | Conditions: Head and Neck Carcinoma | Phase 1 | Status: RECRUITING